Sign In
Buy ALT
$2.87
-0.0300 (-1.03%)
At Close: Jun 03, 2026
Alternus Energy Group completes €9M funding led by asset manager AVG Group Sarl
11:38am, Monday, 12'th Apr 2021
Alternus Energy Group PLC (NOTC:ALT), the fast-growing pan-European independent power producer, announced the recent issuance of €9 million convertible notes lead by AVG Group Sarl, a Luxembourg-bas
Wall Street starts in the red
11:38am, Monday, 12'th Apr 2021
10.15am: Proactive North America headlines: Genprex Inc (NASDAQ:GNPX) presents positive preclinical data for lung cancer drug REQORSA at American Association for Cancer Research meeting Kintara Ther
Could AstraZeneca's Nasal COVID Vaccine Development Zap Altimmune's Prospects?
06:04am, Saturday, 10'th Apr 2021
The short answer: It depends.
Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield™
07:00am, Thursday, 01'st Apr 2021
GAITHERSBURG, Md., April 01, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, reported clinical data today on its NasoShield intranasal anthrax vacci
Alternus Energy drives continued European expansion with completion of 15MWp capacity in Romania
10:29am, Thursday, 25'th Mar 2021
Alternus Energy Group PLC (NOTC:ALT), the fast-growing pan-European independent power producer, has announced the completion of the acquisition of two additional solar parks in Romania from Renesola P
Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine Candidate
07:00am, Monday, 22'nd Mar 2021
Metered Multidose Device Allows for Convenient and Cost-effective Vaccination Metered Multidose Device Allows for Convenient and Cost-effective Vaccination
Is Altimmune a Buy?
07:23am, Saturday, 20'th Mar 2021
If you're thinking of investing in this spectacular coronavirus growth stock, now may be too late.
Intranasal COVID-19 Vaccine Shows Very Promising Preclinical Results
09:57am, Monday, 15'th Mar 2021
Altimmune Inc. (NASDAQ: ALT) is making headway in the fight against COVID-19 after the firm announced additional preclinical data in regards to its single-dose intranasal vaccine candidate, AdCOVID.
ALT Stock Price Increases Over 10% Pre-Market: Why It Happened
08:20am, Monday, 15'th Mar 2021
The stock price of Altimmune Inc (NASDAQ: ALT) has increased by over 10% pre-market. This is why it happened.
Why ContraFect, Evoke, Altimmune, Novavax Are Moving Friday
11:32am, Friday, 12'th Mar 2021
Among the health care stock movers Friday are ContraFect Corporation (NASDAQ: CFRX), Evoke Pharma, Inc. (NASDAQ: EVOK), Altimmune, Inc. (NASDAQ: ALT) and Novavax, Inc. (NASDAQ: NVAX). Here's why the
ALT Stock Price Increases Over 15% Pre-Market: Why It Happened
06:54am, Friday, 12'th Mar 2021
The stock price of Altimmune Inc (NASDAQ: ALT) increased by over 15% pre-market. This is why it happened.
Altimmune Shares Are Trading Higher On Expanded Manufacturing Pact With Lonza
06:10am, Friday, 12'th Mar 2021
Altimmune Inc (NASDAQ: ALT) has expanded its previously-announced manufacturing collaboration with Lonza Group (OTCMKT: LZAGY) for AdCOVID, its single-dose intranasal COVID-19 vaccine candidat
Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
01:00am, Friday, 12'th Mar 2021
Lonza to Commission a Dedicated Suite for Clinical and Commercial Supply of Altimmune's COVID-19 Vaccine Candidate at its Houston Facility Lonza to Commission a Dedicated Suite for Clinical and Commer
Alternus Energy shows turn to positive EBITDA and strong revenue growth in financial results for year ended December 31, 2020
11:42am, Wednesday, 10'th Mar 2021
Alternus Energy Group PLC (NOTC:ALT) has reported a turn to positive EBITDA and strong revenue growth in its financial results for the year ended December 31, 2020 The company, a fast-growing intern
Alternus Energy shows turn to positive EBITDA and strong revenue growth in financial results for the year ended December 31, 2020
09:41am, Wednesday, 10'th Mar 2021
Alternus Energy Group PLC (NOTC:ALT) has reported a turn to positive EBITDA and strong revenue growth in its financial results for the year ended December 31, 2020 The company, a fast-growing intern
